Johnson & Johnson to test coronavirus vaccine in 60,000 volunteers
Shares of the company rose marginally on Thursday, paring their earlier losses, after the Wall Street Journal first reported the news
FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, US, September 17, 2019. REUTERS/Brendan McDermid/File Photo
Johnson & Johnson aims to test its experimental coronavirus vaccine in up to 60,000 volunteers in a late-stage trial scheduled to start in September, according to a US government database of clinical trials.
Shares of the company rose marginally on Thursday, paring their earlier losses, after the Wall Street Journal first reported the news.
Rival coronavirus vaccine makers such as Moderna Inc and Pfizer are targeting recruiting up to 30,000 volunteers for their late-stage studies.
Keep updated, follow The Business Standard's Google news channel
